AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $403.20
- 52-wk high
- $434.35
- High
- $409.43
- 52-wk low
- $270.87
- Low
- $391.69
- Prev close
- $401.94
- Mkt cap
- $86.08B
- P/E
- 17.8x
- Volume
- 1.21M
- Fwd P/E
- 13.8x
- Beta
- 0.70
- Div yield
- 1.71%
- P/S
- 0.4x
- P/B
- 1.9x
- Profit margin
- +2.5%
- Op margin
- +4.6%
- ROE
- +11.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders are trading both ways.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 20.6% above what analysts expected.
Earnings per share
$6.18 expected
Revenue
No comparable estimate
Reports Oct 20, 2026, in 40 days
EPS expected
$4.55 to $4.99
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $50.71B | $49.75B | $50.18B | $50.47B |
| Cost of what it sold | $38.14B | $38.06B | $41.08B | $5.49B |
| Gross profit | $12.57B | $11.68B | $9.10B | $44.98B |
| What it spent | ||||
| Sales and admin | — | — | $6.33B | — |
| Other operating costs | $10.81B | $11.10B | $112.0M | $42.92B |
| Total operating expenses | $10.81B | $11.10B | $6.44B | $42.92B |
| What was left | ||||
| Operating profit | $1.76B | $581.0M | $2.66B | $2.06B |
| Interest on debt | $351.0M | $366.0M | $357.0M | $56.0M |
| Profit before tax | $1.41B | $215.0M | $2.30B | $1.94B |
| Tax | $219.0M | -$331.0M | $544.0M | $483.0M |
| Net profit | $1.19B | $547.0M | $1.76B | $1.46B |
| EBITDA | $2.14B | $987.0M | $2.77B | $2.10B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Elevance Health EVP and Chief Legal Officer Wessling Erin M Forfeits 349 Shares, Retains 7,230 Shares
NeutralSep 8Elevance Health (ELV) Q2 2026 Earnings Call Transcript
NeutralSep 5Health insurer Anthem targeted in lawsuit over air ambulance claims
BearishSep 5Elevance Health (NYSE: ELV) withholds 349 shares to cover EVP tax liability
NeutralSep 4EVP at Elevance Health (NYSE: ELV) now holds 6,530 shares after tax withholding
NeutralSep 4Elevance Worker Pay Class Suit Heads Toward Settlement Over Delayed Paychecks
Leans bearishSep 4Elevance Health Inc. stock underperforms Friday when compared to competitors
Leans bearishSep 4Elevance Health (NYSE:ELV) Valuation Gap Persists After Rally
Leans bullishSep 4
Macro
22 macro signals shaping ELV right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results